• info@kellerrohrback.com |
  • (800) 776-6044
Keller Rohrback | Complex Litigation Law Firm
  • Home
  • Attorneys
  • Cases
    • Current Investigations
    • Active Cases
  • Practice Areas
    • Antitrust and Trade Regulation
    • Employee Benefits and Retirement Security
    • Institutional Investors
    • Appeals
    • Employment Law
    • International Law
    • Bankruptcy & Financial Restructuring
    • Environmental Litigation
    • Mass Personal Injury
    • Class Action and Consumer Litigation
    • Financial Products and Services
    • Mortgage Put-Back Litigation
    • Consumer and Data Privacy Protection
    • Governments and Municipalities
    • Opioid Litigation
    • Securities
    • Whistleblower
  • Our Successes
  • Our Firm
  • News
    • Drug Overcharges Resource Center
    • Audi Emissions Cheating Resource Center
    • Church Plan ERISA Litigation Resource Center
    • Fiat Chrysler Emissions Cheating Resource Center
    • Volkswagen Diesel Resource Center
  • Contact
    • Locations
Select Page
Keller Rohrback Investigates OptumRx, UnitedHealthcare, & Cigna for Inflating Prescription Copays

Keller Rohrback Investigates OptumRx, UnitedHealthcare, & Cigna for Inflating Prescription Copays

by KellerRohrback | Oct 26, 2016 | Consumer and Data Privacy Protection |

Keller Rohrback L.L.P. Investigates OptumRx, UnitedHealthcare, and Cigna for Inflating Prescription Copays Keller Rohrback L.L.P. is investigating recent reports that OptumRx, UnitedHealthcare, and Cigna are forcing patients to overpay for prescriptions by charging a...
Court Grants Final Approval 2.0-Liter Settlement

Court Grants Final Approval 2.0-Liter Settlement

by KellerRohrback | Oct 25, 2016 | Volkswagen Diesel Resource Center |

Court Grants Final Approval to 2.0-Liter Settlement Keller Rohrback is pleased to report that this morning, Judge Charles Breyer granted final approval to the 2.0L class action TDI settlement. In the settlement approved today, October 25, 2016, in the Volkswagen...
UnitedHealthcare and OptumRx Overcharge Their Customers for Prescription Drugs

UnitedHealthcare and OptumRx Overcharge Their Customers for Prescription Drugs

by KellerRohrback | Oct 20, 2016 | Consumer and Data Privacy Protection |

OptumRX, UnitedHealthcare, Cigna, and Catamaran Overcharge Patients for Prescription Drugs   Recent investigations show that OptumRx, UnitedHealthcare, Cigna, and Catamaran  make their customers overpay for many commonly-used medicines. For example, if a drug...
“Surreptitious lobbying” for EpiPen called into question by recent report

“Surreptitious lobbying” for EpiPen called into question by recent report

by KellerRohrback | Oct 19, 2016 | Consumer and Data Privacy Protection |

“Surreptitious lobbying” for EpiPen called into question by recent report; Keller Rohrback seeks relief on behalf of consumers According to a recent report by STAT news, “Mylan Pharmaceuticals has [begun] . . . a surreptitious lobbying campaign to have its [EpiPen]...
KR is Investigating Samsung Galaxy Note 7 Smartphones Recalled for Catching Fire or Exploding While Charging

KR is Investigating Samsung Galaxy Note 7 Smartphones Recalled for Catching Fire or Exploding While Charging

by KellerRohrback | Oct 13, 2016 | Consumer and Data Privacy Protection |

KR is Investigating Samsung Galaxy Note 7 Smartphones Recalled for Catching Fire or Exploding While Charging Keller Rohrback L.L.P. is investigating the recent recall of the newly launched Samsung Galaxy Note 7 Smartphones that pose an immediate safety risk and have...
Forward »



Clear

Twitter

Tweets by KellerRohrback
  • Facebook
  • Twitter

Privacy Policy | Disclaimer | Careers

Seattle | Oakland | New York | Phoenix | Santa Barbara | Missoula

Case results depend on a variety of factors unique to each case. Case results do not guarantee or predict a similar result in any future case.